AFRIN Side Effects

6825850-3 | Ageusia, Anosmia
on Jul 07, 2010 Male patient from UNITED STATES , 21 years of age, weighting 170.0 lb, was diagnosed with sinus headache and was treated with Afrin (View Usage). Patient experienced the following unwanted or unexpected effects: ageusia, anosmia. Afrin dosage: 2 Sprays In Each Nostril 2x Daily For 2 Day Nasal.

6796304-8 | Ageusia, Anosmia
Patient was taking Afrin (View Usage). Patient had the following side effects: ageusia, anosmia on Jun 24, 2010 from UNITED STATES Additional patient health information: Female patient , 33 years of age, weighting 170.0 lb, was diagnosed with nasal congestion and. Afrin dosage: 2-3 Sprays In Each Nostril Every 10-12 Hours Nasal.

6750520-X | Rhinorrhoea, Sneezing
Adverse event was reported on May 28, 2010 by a Male patient taking Afrin (View Usage) (Dosage: Two Sprays In Each Nostril Once Nasal) was diagnosed with nasal congestion and. Location: UNITED STATES , 87 years of age, weighting 165.0 lb, After Afrin was administered, patient had the following side effects: rhinorrhoea, sneezing.

6730562-0 | Acute Pulmonary Oedema, Blood Pressure Increased, Haemoptysis, Heart Rate Decreased, Mean Arterial Pressure Increased, Mitral Valve Incompetence, Nodal Rhythm, Pulmonary Congestion
on Apr 29, 2010 Female patient from UNITED STATES , 28 years of age, was diagnosed with endotracheal intubation and was treated with Afrin (View Usage). Patient experienced the following unwanted or unexpected effects: acute pulmonary oedema, blood pressure increased, haemoptysis, heart rate decreased, mean arterial pressure increased, mitral valve incompetence, nodal rhythm, pulmonary congestion. Afrin dosage: 4 Df; Once; Nasal, 16 Df; Once; Nasal. During the same period patient was treated with ORTHO EVRA (View Ortho Evra Review and Ortho Evra Label ), ANESTHETICS (View Anesthetics Review and Anesthetics Label ).


6702987-0 | Anosmia, Dysgeusia, Feeling Abnormal, Inflammation, Rebound Effect
on Apr 29, 2010 Male patient from UNITED STATES , 23 years of age, weighting 235.0 lb, was diagnosed with nasopharyngitis and was treated with Afrin (View Usage). Patient had the following side effects: anosmia, dysgeusia, feeling abnormal, inflammation, rebound effect. Afrin dosage: 1 Spray -diluted 50% Saline- 1 Every 11 Hours Nasal.

6629665-0 | Feeling Abnormal, Hypogeusia, Hyposmia
Patient was taking Afrin (View Usage). After Afrin was administered, patient had the following side effects: feeling abnormal, hypogeusia, hyposmia on Mar 10, 2010 from UNITED STATES Additional patient health information: Female patient , 35 years of age, weighting 205.0 lb, was diagnosed with nasal congestion and. Afrin dosage: 2-3 Sprays In Each Nostril Once A Day Nasal.

6575749-5 | Burning Sensation, Dyspnoea, Eye Pain, Lacrimation Increased, Nasal Discomfort, Ocular Hyperaemia, Oropharyngeal Pain, Throat Tightness
Adverse event was reported on Jan 22, 2010 by a Female patient taking Afrin (View Usage) (Dosage: Once; Nas) was diagnosed with hypersensitivity, nasal congestion and. Location: UNITED STATES , 43 years of age, weighting 120.0 lb, Patient experienced the following unwanted or unexpected effects: burning sensation, dyspnoea, eye pain, lacrimation increased, nasal discomfort, ocular hyperaemia, oropharyngeal pain, throat tightness.

6471310-1 | Dependence
on Nov 20, 2009 Male patient from UNITED STATES , 45 years of age, was diagnosed with nasal congestion, sleep disorder (What is sleep disorder?) and was treated with Afrin (View Usage). Patient had the following side effects: dependence. Afrin dosage: Qd;nas. During the same period patient was treated with CODEINE (View Codeine Review and Codeine Label ), MORPHINE (View Morphine Review and Morphine Label ), OXYCONTIN (View Oxycontin Review and Oxycontin Label ), AMBIEN (View Ambien Review and Ambien Label ), XANAX (View Xanax Review and Xanax Label ), LOVASTATIN (View Lovastatin Review and Lovastatin Label ).

6454565-9 | Amnesia, Apnoea, Bradycardia, Mental Status Changes, Respiratory Depression, Vomiting
on Nov 06, 2009 Male patient from UNITED STATES , 15 years of age, was diagnosed with pharyngeal haemorrhage and was treated with Afrin (View Usage). After Afrin was administered, patient had the following side effects: amnesia, apnoea, bradycardia, mental status changes, respiratory depression, vomiting. Afrin dosage: Tid; Po. Patient was hospitalized.

6424129-1 | Hypersensitivity
Patient was taking Afrin (View Usage). Patient experienced the following unwanted or unexpected effects: hypersensitivity on Oct 14, 2009 from UNITED STATES Additional patient health information: Female patient , child 5 years of age, . Afrin dosage: Nas. Patient was hospitalized.

6355959-2 | Anosmia, Hypogeusia
Adverse event was reported on Sep 14, 2009 by a Male patient taking Afrin (View Usage) (Dosage: 2 Or 3 Sprays Every 12 Hours Nasal) was diagnosed with nasopharyngitis and. Location: UNITED STATES , weighting 215.0 lb, Patient had the following side effects: anosmia, hypogeusia.

6287550-0 | Dyspnoea, Sinus Disorder
on Jul 20, 2009 Female patient from UNITED STATES , 54 years of age, weighting 117.0 lb, was diagnosed with sinus congestion and was treated with Afrin (View Usage). After Afrin was administered, patient had the following side effects: dyspnoea, sinus disorder. Afrin dosage: Nas. During the same period patient was treated with AFRIN TM PEDIATRIC NASAL SOLUTION/DROPS (Nas) (View Afrin-tm Pediatric Nasal Solution/drops Review and Afrin-tm Pediatric Nasal Solution/drops Label ), MULTI VITAMIN (View Multi-vitamin Review and Multi-vitamin Label ), AFRIN EXTRA MOISTURISING NASAL SPRAY (View Afrin Extra Moisturising Nasal Spray Review and Afrin Extra Moisturising Nasal Spray Label ).

6287550-0 | Dyspnoea, Sinus Disorder
on Jul 20, 2009 Female patient from UNITED STATES , 54 years of age, weighting 117.0 lb, was diagnosed with sinus congestion and was treated with Afrin (View Usage). Patient experienced the following unwanted or unexpected effects: dyspnoea, sinus disorder. Afrin dosage: Nas. During the same period patient was treated with MULTI VITAMIN (View Multi-vitamin Review and Multi-vitamin Label ).

6268795-2 | Cerebral Artery Thrombosis
Patient was taking Afrin (View Usage). Patient had the following side effects: cerebral artery thrombosis on Jul 10, 2009 from UNITED STATES Additional patient health information: Female patient , 43 years of age, weighting 154.3 lb, was diagnosed with rhinitis allergic and. Afrin dosage: . Patient was hospitalized.

6253142-2 | Hypogeusia, Hyposmia
Adverse event was reported on Jun 29, 2009 by a Male patient taking Afrin (View Usage) (Dosage: 2 Sprays Per Dose 4 Times A Year Nasal) was diagnosed with ear discomfort and. Location: UNITED STATES , 29 years of age, weighting 143.0 lb, After Afrin was administered, patient had the following side effects: hypogeusia, hyposmia.

6183722-4 | Product Label Confusion, Rebound Effect
on May 06, 2009 Male patient from UNITED STATES , 48 years of age, weighting 148.0 lb, was diagnosed with nasal congestion and was treated with Afrin (View Usage). Patient experienced the following unwanted or unexpected effects: product label confusion, rebound effect. Afrin dosage: 2-3 Sprays Per Nostril Q 10-12 Hrs Nasal.

5961137-9 | Heart Rate Increased
on Nov 17, 2008 Male patient from UNITED STATES , 76 years of age, weighting 246.0 lb, was diagnosed with nasopharyngitis, off label use and was treated with Afrin (View Usage). Patient had the following side effects: heart rate increased. Afrin dosage: Qd; Nas. During the same period patient was treated with SYNTHROID (Po) (View Synthroid Review and Synthroid Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), COLCHICINE (View Colchicine Review and Colchicine Label ), CARVEDILOL (View Carvedilol Review and Carvedilol Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), SINVASTATIN (View Sinvastatin Review and Sinvastatin Label ), MECLIZINE (View Meclizine Review and Meclizine Label ). Patient was hospitalized.

5933405-8 | Heart Rate Decreased, Heart Rate Increased
Patient was taking Afrin (View Usage). After Afrin was administered, patient had the following side effects: heart rate decreased, heart rate increased on Oct 09, 2008 from UNITED STATES Additional patient health information: Male patient , 76 years of age, weighting 246.0 lb, was diagnosed with nasopharyngitis, off label use and. Afrin dosage: Qd; Nas. During the same period patient was treated with SYNTHROID (Po) (View Synthroid Review and Synthroid Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), COLCHICINE (View Colchicine Review and Colchicine Label ), CARVEDILOL (View Carvedilol Review and Carvedilol Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), SINVASTATIN (View Sinvastatin Review and Sinvastatin Label ), MECLIZINE (View Meclizine Review and Meclizine Label ). Patient was hospitalized.

5923255-0 | Heart Rate Increased
Adverse event was reported on Oct 03, 2008 by a Male patient taking Afrin (View Usage) (Dosage: ;qd;nas) was diagnosed with nasopharyngitis, off label use and. Location: UNITED STATES , 76 years of age, weighting 246.0 lb, Patient experienced the following unwanted or unexpected effects: heart rate increased. Patient was hospitalized.

5808256-5 | Blood Pressure Increased
on Jun 24, 2008 Female patient from UNITED STATES , 38 years of age, was treated with Afrin (View Usage). Patient had the following side effects: blood pressure increased. Afrin dosage: Bid. During the same period patient was treated with SYNTHROID (View Synthroid Review and Synthroid Label ).

5778490-1 | Nasal Disorder
on Jun 06, 2008 Female patient from UNITED STATES , 38 years of age, was treated with Afrin (View Usage). After Afrin was administered, patient had the following side effects: nasal disorder. Afrin dosage: Prn.

5765668-6 | Ageusia, Anosmia, Intranasal Hypoaesthesia
Patient was taking Afrin (View Usage). Patient experienced the following unwanted or unexpected effects: ageusia, anosmia, intranasal hypoaesthesia on Jun 09, 2008 from UNITED STATES Additional patient health information: Female patient , weighting 135.0 lb, was diagnosed with nasopharyngitis and. Afrin dosage: 2 Or 3 Sprays In Each Nostril 10-12 Hours Nasal.

5765264-0 | Dysgeusia, Hyposmia
Adverse event was reported on Jun 09, 2008 by a Female patient taking Afrin (View Usage) (Dosage: 2 Or 3 Sprays In Each Nostril 10-12 Hours Nasal) was diagnosed with nasal congestion and. Location: UNITED STATES , weighting 110.0 lb, Patient had the following side effects: dysgeusia, hyposmia.

5656587-4 | Asthma, Condition Aggravated, Dependence
on Mar 06, 2008 Female patient from UNITED STATES , 25 years of age, weighting 115.0 lb, was diagnosed with nasal congestion and was treated with Afrin (View Usage). After Afrin was administered, patient had the following side effects: asthma (What is asthma?), condition aggravated, dependence. Afrin dosage: 2 To 3 Sprays In Each Nostril Every 10-12 Hrs Nasal.

5509349-2 | Depression, Fatigue, Insomnia, Migraine, Nasal Congestion, Nasal Mucosal Disorder, Panic Attack
on Oct 24, 2007 Female patient from UNITED STATES , 20 years of age, was diagnosed with multiple allergies, sinus disorder and was treated with Afrin (View Usage). Patient experienced the following unwanted or unexpected effects: depression (What is depression?), fatigue, insomnia, migraine (What is migraine?), nasal congestion, nasal mucosal disorder, panic attack. Afrin dosage: Nas.

5504764-5 | Abnormal Behaviour, Economic Problem, Emotional Distress, Fear, Thinking Abnormal, Voluntary Redundancy
Patient was taking Afrin (View Usage). Patient had the following side effects: abnormal behaviour, economic problem, emotional distress, fear, thinking abnormal, voluntary redundancy on Oct 31, 2007 from UNITED STATES Additional patient health information: Female patient , 44 years of age, weighting 135.0 lb, was diagnosed with hypersensitivity, nasopharyngitis, sinus disorder and. Afrin dosage: Puffs Every 12 Hours Nose.

5502843-X | Dependence, Nasal Discomfort, Nasal Ulcer
Adverse event was reported on Oct 22, 2007 by a Male patient taking Afrin (View Usage) (Dosage: Nas) was diagnosed with dyspnoea and. Location: UNITED STATES , 44 years of age, After Afrin was administered, patient had the following side effects: dependence, nasal discomfort, nasal ulcer.

5487645-5 | Depression, Dyspnoea, Fatigue, Ill-defined Disorder, Insomnia, Migraine, Nasal Congestion, Panic Attack
on Oct 12, 2007 Female patient from UNITED STATES , child 12 years of age, weighting 150.0 lb, was diagnosed with hypersensitivity, rhinitis, sinusitis (What is sinusitis?) and was treated with Afrin (View Usage). Patient experienced the following unwanted or unexpected effects: depression (What is depression?), dyspnoea, fatigue, ill-defined disorder, insomnia, migraine (What is migraine?), nasal congestion, panic attack. Afrin dosage: Several Times A Da.

5485479-9 | Convulsion, Electroencephalogram Abnormal, Incorrect Dose Administered
on Oct 10, 2007 Male patient from UNITED STATES , weighting 138.0 lb, was diagnosed with nasopharyngitis and was treated with Afrin (View Usage). Patient had the following side effects: convulsion, electroencephalogram abnormal, incorrect dose administered. Afrin dosage: 2 Or 3 Sprays Per Dose 2 Or 3 Times A Day Nasal. Patient was hospitalized.

5256955-9 | Anxiety, Nasal Congestion, Nasopharyngitis, Rebound Effect, Swelling
Patient was taking Afrin (View Usage). After Afrin was administered, patient had the following side effects: anxiety (What is anxiety?), nasal congestion, nasopharyngitis, rebound effect, swelling on Mar 05, 2007 from UNITED STATES Additional patient health information: Male patient , 43 years of age, weighting 210.0 lb, was diagnosed with nasal congestion, nasopharyngitis and. Afrin dosage: Qh; Nas. During the same period patient was treated with LANOXIN (View Lanoxin Review and Lanoxin Label ), CARDIZEM (View Cardizem Review and Cardizem Label ), VITAMINS (View Vitamins Review and Vitamins Label ), PAROXETINE HCL (View Paroxetine Hcl Review and Paroxetine Hcl Label ), VIOXX (View Vioxx Review and Vioxx Label ), SINGULAIR (View Singulair Review and Singulair Label ), CELEBREX (View Celebrex Review and Celebrex Label ).

5247316-7 | Anxiety, Disturbance In Social Behaviour, Nasal Congestion, Rebound Effect, Rhinitis
Adverse event was reported on Feb 23, 2007 by a Male patient taking Afrin (View Usage) (Dosage: ;qh;nas) was diagnosed with nasal congestion, nasopharyngitis and. Location: UNITED STATES , 43 years of age, weighting 205.0 lb, Patient experienced the following unwanted or unexpected effects: anxiety (What is anxiety?), disturbance in social behaviour, nasal congestion, rebound effect, rhinitis. During the same period patient was treated with LANOXIN (View Lanoxin Review and Lanoxin Label ), CARDIZEM (View Cardizem Review and Cardizem Label ), VITAMINS (View Vitamins Review and Vitamins Label ).

5203783-6 | Accidental Exposure, Arrhythmia Supraventricular, Bradycardia, Cardiac Disorder, Dizziness Postural, Dyspnoea, Extrasystoles, Hypertension, Malaise
on Jan 09, 2007 Male patient from COLOMBIA , 22 years of age, was diagnosed with rhinoplasty and was treated with Afrin (View Usage). Patient had the following side effects: accidental exposure, arrhythmia supraventricular, bradycardia, cardiac disorder, dizziness postural, dyspnoea, extrasystoles, hypertension, malaise. Afrin dosage: 10 Ml; Once; Nas. Patient was hospitalized.

5166559-4 | Bradycardia, Hypertension, Malaise, Procedural Complication, Supraventricular Tachycardia
on Nov 30, 2006 Male patient from COLOMBIA , 22 years of age, was diagnosed with rhinoplasty and was treated with Afrin (View Usage). After Afrin was administered, patient had the following side effects: bradycardia, hypertension, malaise, procedural complication, supraventricular tachycardia. Afrin dosage: 10 Ml;nas. Patient was hospitalized.

4965783-0 | Dyspnoea, Hallucination, Visual, Insomnia, Nasopharyngitis
Patient was taking Afrin (View Usage). Patient experienced the following unwanted or unexpected effects: dyspnoea, hallucination, visual, insomnia, nasopharyngitis on Apr 05, 2006 from UNITED STATES Additional patient health information: Male patient , 69 years of age, weighting 240.0 lb, was diagnosed with nasopharyngitis and. Afrin dosage: Prn Nasal Spray. During the same period patient was treated with GARLIC (View Garlic Review and Garlic Label ), OMEGA 3 POLYUNSATURATED FATTY ACIDS (View Omega-3 Polyunsaturated Fatty Acids Review and Omega-3 Polyunsaturated Fatty Acids Label ), COENZYME Q10 (View Coenzyme Q10 Review and Coenzyme Q10 Label ), ASPIRIN (View Aspirin Review and Aspirin Label ).

4947934-7 | Hallucination, Insomnia
Adverse event was reported on Mar 17, 2006 by a Male patient taking Afrin (View Usage) (Dosage: Nasal Spray) was diagnosed with nasopharyngitis and. Location: UNITED STATES , 69 years of age, weighting 230.0 lb, Patient had the following side effects: hallucination, insomnia. During the same period patient was treated with GARLIC (View Garlic Review and Garlic Label ), OMEGA 3 POLYUNSATURATED FATTY ACIDS (View Omega-3 Polyunsaturated Fatty Acids Review and Omega-3 Polyunsaturated Fatty Acids Label ), COENZYME Q10 (View Coenzyme Q10 Review and Coenzyme Q10 Label ).

4677727-X | Benign Prostatic Hyperplasia, Condition Aggravated, Discomfort, Prostatitis, Urinary Retention
on May 26, 2005 Male patient from , 60 years of age, was diagnosed with nasopharyngitis and was treated with Afrin (View Usage). After Afrin was administered, patient had the following side effects: benign prostatic hyperplasia, condition aggravated, discomfort, prostatitis, urinary retention. Afrin dosage: Nas Aer Spray. During the same period patient was treated with COZAAR (View Cozaar Review and Cozaar Label ), LIPITOR (View Lipitor Review and Lipitor Label ), FLOMAX (View Flomax Review and Flomax Label ), VITAMINS/MINERALS/DIETARY SUPPLEMENTS (NOS) (View Vitamins/minerals/dietary Supplements (nos) Review and Vitamins/minerals/dietary Supplements (nos) Label ).

4666198-5 |
on May 05, 2005 Female patient from , 72 years of age, was diagnosed with nasal congestion and was treated with Afrin (View Usage). . Afrin dosage: Nasal Spray. During the same period patient was treated with AERIUS (DESLORATADINE) (Oral) (View Aerius (desloratadine) Review and Aerius (desloratadine) Label ), TEGRETOL (View Tegretol Review and Tegretol Label ), VENTOLIN (View Ventolin Review and Ventolin Label ), ATROVENT (View Atrovent Review and Atrovent Label ), PULMICORT (View Pulmicort Review and Pulmicort Label ), SCOPOLAMINE (View Scopolamine Review and Scopolamine Label ), PHENOBARBITAL (View Phenobarbital Review and Phenobarbital Label ). Patient was hospitalized.

4651970-8 | Agitation, Amnesia, Confusional State, Legal Problem, Physical Assault, Speech Disorder, Thinking Abnormal
Patient was taking Afrin (View Usage). Patient had the following side effects: agitation, amnesia, confusional state, legal problem, physical assault, speech disorder, thinking abnormal on May 02, 2005 from Additional patient health information: Male patient , 35 years of age, was diagnosed with seasonal allergy, hypothyroidism and. Afrin dosage: . During the same period patient was treated with SUDAFED 12 HOUR (View Sudafed 12 Hour Review and Sudafed 12 Hour Label ), ARMOUR THYROID TABLETS (60 Mg Qd Oral) (View Armour Thyroid Tablets Review and Armour Thyroid Tablets Label ). Patient was hospitalized.

4642342-0 | Benign Prostatic Hyperplasia, Condition Aggravated, Discomfort, Dysuria, Pollakiuria, Prostatitis, Urinary Retention, Urine Flow Decreased
Adverse event was reported on Apr 21, 2005 by a Male patient taking Afrin (View Usage) (Dosage: Nas Aer Spray) was diagnosed with nasopharyngitis and. Location: , 60 years of age, After Afrin was administered, patient had the following side effects: benign prostatic hyperplasia, condition aggravated, discomfort, dysuria, pollakiuria, prostatitis, urinary retention, urine flow decreased. During the same period patient was treated with COZAAR (View Cozaar Review and Cozaar Label ), LIPITOR (View Lipitor Review and Lipitor Label ), FLOMAX (View Flomax Review and Flomax Label ), VITAMINS/MINERALS/DIETARY SUPPLEMENTS (View Vitamins/minerals/dietary Supplements Review and Vitamins/minerals/dietary Supplements Label ).

4575930-0 | Accidental Exposure, Aphonia, Bronchospasm, Dysphonia, Dyspnoea, Erythema, Feeling Hot
on Feb 01, 2005 Male patient from , 49 years of age, weighting 90.00 lb, was treated with Afrin (View Usage). Patient experienced the following unwanted or unexpected effects: accidental exposure, aphonia, bronchospasm, dysphonia, dyspnoea, erythema, feeling hot. Afrin dosage: 5 Sprays Oral. Patient was hospitalized.

4553718-4 | Aphonia, Bronchospasm, Dyspnoea, Erythema, Feeling Hot
on Jan 13, 2005 Male patient from , 49 years of age, weighting 90.00 lb, was treated with Afrin (View Usage). Patient had the following side effects: aphonia, bronchospasm, dyspnoea, erythema, feeling hot. Afrin dosage: 5 Sprays. Patient was hospitalized.